Mannosylated poly(beta-amino esters) for targeted antigen presenting cell immune modulation.

Area of Science:

• Biotechnology
• Immunology
• Materials Science

Background:

• Antibiotic resistance necessitates novel preventative strategies like genetic vaccination.
• Current gene delivery vectors lack specificity, inefficiently targeting key immune cells like antigen-presenting cells (APCs).
• Targeting APCs allows precise control over the type and strength of immune responses.

Purpose of the Study:

• To develop and evaluate mannosylated poly(beta-amino esters) (PBAEs) as a new class of APC-targeting cationic polymers.
• To assess the physiochemical properties and gene delivery capabilities of these novel polymers.
• To investigate the in vivo immune response elicited by mannosylated PBAE-mediated genetic vaccination.

Main Methods:

• Synthesis and characterization of a library of mannosylated PBAEs.
• In vitro assessment of gene delivery efficiency and mannose-mediated uptake.
• In vivo evaluation of humoral immune response in comparison to control antigens.

Main Results:

• Mannosylation significantly improved in vitro gene delivery by PBAEs, indicating mannose-receptor mediated uptake.
• Mannosylated PBAEs demonstrated potent, efficient, and safe in vivo humoral immune responses without adjuvants.
• The developed vectors showed specificity and potency in directing APC activation and immune responses.

Conclusions:

• Mannosylated PBAEs represent a novel and effective class of APC-targeting vectors for genetic vaccination.
• These polymers offer a promising platform for developing targeted and potent immune responses against various diseases.
• The findings support the potential of tailored gene delivery systems in advancing preventative medicine.